High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors

• मुख्य लेखकों: Ariane Fizazi (लेखक), Chris Serrand (लेखक), Alexandre Evrard (लेखक), Blanche Bergeret (लेखक), Pierre-Emmanuel Stoebner (लेखक), Myriam Marque (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Medical Journals Sweden, 2024-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The prognostic value of BRAF V600 mutation level on clinical outcomes in patients with BRAF V600-mutated metastatic melanoma treated with BRAF and MEK inhibitors remains uncertain. The association was retrospectively analysed between BRAF V600 mutation level (defined as the ratio of the quantificati...